Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005;50(4):192-202.
doi: 10.1007/s10038-005-0239-7. Epub 2005 Apr 15.

Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia

Tetsuya Niihori  1 , Yoko Aoki  2 , Hirofumi Ohashi  3 , Kenji Kurosawa  4 , Tatsuro Kondoh  5 , Satoshi Ishikiriyama  6 , Hiroshi Kawame  7 , Hotaka Kamasaki  8 , Tsutomu Yamanaka  9 , Fumio Takada  10 , Kimio Nishio  11 , Masahiro Sakurai  12 , Hiroshi Tamai  13 , Tatsuro Nagashima  14 , Yoichi Suzuki  1 , Shigeo Kure  1 , Kunihiro Fujii  15 , Masue Imaizumi  16 , Yoichi Matsubara  1
Affiliations

Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia

Tetsuya Niihori et al. J Hum Genet. 2005.

Abstract

Noonan syndrome (NS) is characterized by short stature, characteristic facial features, and heart defects. Recently, missense mutations of PTPN11, the gene encoding protein tyrosine phosphatase (PTP) SHP-2, were identified in patients with NS. Further, somatic mutations in PTPN11 were detected in childhood leukemia. Recent studies showed that the phosphatase activities of five mutations identified in NS and juvenile myelomonocytic leukemia (JMML) were increased. However, the functional properties of the other mutations remain unidentified. In this study, in order to clarify the differences between the mutations identified in NS and leukemia, we examined the phosphatase activity of 14 mutants of SHP-2. We identified nine mutations, including a novel F71I mutation, in 16 of 41 NS patients and two mutations, including a novel G503V mutation, in three of 29 patients with leukemia. Immune complex phosphatase assays of individual mutants transfected in COS7 cells showed that ten mutants identified in NS and four mutants in leukemia showed 1.4-fold to 12.7-fold increased activation compared with wild-type SHP-2. These results suggest that the pathogenesis of NS and leukemia is associated with enhanced phosphatase activity of mutant SHP-2. A comparison of the phosphatase activity in each mutant and a review of previously reported cases showed that high phosphatase activity observed in mutations at codons 61, 71, 72, and 76 was significantly associated with leukemogenesis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Pediatr. 2004 Mar;144(3):368-74 - PubMed
    1. Mol Cell Biol. 1996 Mar;16(3):1189-202 - PubMed
    1. Blood. 2004 Mar 15;103(6):2325-31 - PubMed
    1. Gene. 1991 Dec 15;108(2):193-9 - PubMed
    1. Hum Mutat. 2004 Mar;23(3):267-77 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

-